Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
NYU Langone Health
Dana-Farber Cancer Institute
Universitätsklinikum Hamburg-Eppendorf
Barbara Ann Karmanos Cancer Institute
St. Jude Children's Research Hospital